Comment on “Biomarkers as Potential Treatment Targets in Inflammatory Bowel Disease: A Systematic Review”
Joint Authors
Delicata, Nicholas-Paul
Azzopardi, Neville
Ellul, Pierre
Source
Canadian Journal of Gastroenterology and Hepatology
Issue
Vol. 2016, Issue 2016 (31 Dec. 2016), pp.1-2, 2 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2016-03-31
Country of Publication
Egypt
No. of Pages
2
Main Subjects
Abstract EN
We read with interest the article entitled “Biomarkers as Potential Treatment Targets in Inflammatory Bowel Disease: A Systemic Review,” which brings forward evidence that serum and faecal biomarkers do not possess adequate operational characteristics to make them stand-alone treatment targets in inflammatory bowel disease (IBD) but should be considered as important adjunctive measures to clinical, endoscopic, and radiographic assessment [1].
American Psychological Association (APA)
Delicata, Nicholas-Paul& Azzopardi, Neville& Ellul, Pierre. 2016. Comment on “Biomarkers as Potential Treatment Targets in Inflammatory Bowel Disease: A Systematic Review”. Canadian Journal of Gastroenterology and Hepatology،Vol. 2016, no. 2016, pp.1-2.
https://search.emarefa.net/detail/BIM-1099866
Modern Language Association (MLA)
Delicata, Nicholas-Paul…[et al.]. Comment on “Biomarkers as Potential Treatment Targets in Inflammatory Bowel Disease: A Systematic Review”. Canadian Journal of Gastroenterology and Hepatology No. 2016 (2016), pp.1-2.
https://search.emarefa.net/detail/BIM-1099866
American Medical Association (AMA)
Delicata, Nicholas-Paul& Azzopardi, Neville& Ellul, Pierre. Comment on “Biomarkers as Potential Treatment Targets in Inflammatory Bowel Disease: A Systematic Review”. Canadian Journal of Gastroenterology and Hepatology. 2016. Vol. 2016, no. 2016, pp.1-2.
https://search.emarefa.net/detail/BIM-1099866
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1099866
